Wave Life Sciences Ltd.
NASDAQ:WVE
| Market Cap (Intraday) | 374.58M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.74 |
| 50-Day MA | $4.94 |
| 200-Day MA | $3.49 |
Wave Life Sciences Ltd. Stock, NASDAQ:WVE
Marina One East Tower, 7 Straits View, Singapore, Central Singapore 018936
Singapore
Phone: +65.6236.3388
Number of Employees: 238
Description
Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.